Skip to content

Mitochondrial Complex I Deficiency Nuclear Type 17 C4748786

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder affecting the first complex of the mitochondria, impairing the cell's ability to generate energy. It may cause neurological, muscular, or metabolic problems. Treatment is supportive and individualized.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Developmental delay

(metabolic)

Muscle weakness

(metabolic)

Cardiomyopathy

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Hepatic function surveillance

Regular liver function tests and imaging to monitor for hepatomegaly, hepatic dysfunction, or progression of liver disease in mitochondrial complex I deficiency.

monitoring
3

Hepatic-protective nutrition

Nutritional support with adequate calories, protein, and micronutrients while avoiding hepatotoxic substances and managing fat metabolism.

dietary

Additional treatment options

Mitochondrial-targeted antioxidant therapy

General antioxidant supplementation to reduce oxidative stress on hepatic mitochondria and support cellular energy metabolism.

medication

Alcohol and toxin avoidance

Strict elimination of alcohol, acetaminophen, and other hepatotoxic substances that can compound mitochondrial liver dysfunction.

lifestyle

Specialized hepatology referral

Gastroenterology/hepatology consultation for advanced hepatic assessment, biopsy consideration, and management of complications such as portal hypertension.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Mitochondrial Complex I Deficiency Nuclear Type 17 C4748786?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Mitochondrial Complex I Deficiency Nuclear Type 17 C4748786. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy